Showing results (31-40 of 47) with videos related to
Sort By:
Pageof 5
Journal of Pharmaceutical Health Care and Sciences|August 1, 2021
Impact of an antimicrobial stewardship in a 126-bed community hospital with close communication between pharmacists working on post-prescription audit, ward pharmacists, and the antimicrobial stewardship teamSatoshi Nakamura, Takashi Arima, Ryoichi Tashiro, et al.Bioscience, Biotechnology, and Biochemistry|September 9, 2008
Photoisomerization of 2-[3-(2-thioxopyrrolidin-3-ylidene)methyl]-tryptophan, a yellow pigment in salted radish rootsHiroki Matsuoka, Shuji Honzawa, Asaka Takahashi, et al.Nihon Hoshasen Gijutsu Gakkai Zasshi|December 2, 2006
[Status of measures against angiography room infection as determined by questionnaire]Atsuko Tsukamoto, Makiko Ito, Kanji Takahashi, et al.Environmental Health and Preventive Medicine|March 15, 2022
Stair climbing and incident atrial fibrillation: a prospective cohort studyAhmed Arafa, Yoshihiro Kokubo, Keiko Shimamoto, et al.The EPMA Journal|March 11, 2022
Sleep duration and atrial fibrillation risk in the context of predictive, preventive, and personalized medicine: the Suita Study and meta-analysis of prospective cohort studiesAhmed Arafa, Yoshihiro Kokubo, Keiko Shimamoto, et al.Circulation. Cardiovascular Quality and Outcomes|November 25, 2010
Use of antithrombotic medications among elderly ischemic stroke patientsJudith H Lichtman, Lisa Naert, Norrina B Allen, et al.Journal of Atherosclerosis and Thrombosis|November 22, 2021
Weight Change Since Age 20 and the Risk of Cardiovascular Disease Mortality: A Prospective Cohort StudyAhmed Arafa, Yoshihiro Kokubo, Haytham A Sheerah, et al.Dysphagia|September 1, 2017
The Criteria of Thickened Liquid for Dysphagia Management in JapanEmi Watanabe, Yoshie Yamagata, Junko Fujitani, et al.Acta Diabetologica|August 16, 2022
Liver enzymes, alcohol consumption and the risk of diabetes: the Suita studyJiaqi Li, Ahmed Arafa, Rena Kashima, et al.Journal of Medical Economics|April 27, 2016
Clinical and economic impact of rivaroxaban on the burden of atrial fibrillation: The case study of JapanMasatsugu Hori, Shunya Ikeda, Ken Okumura, et al.Pageof 5